Join our mailing list

NewYorkBIO supports the development and growth of New York State'’s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development.

Join NewYorkBIO and help build the Empire State's life science future!


  • Save money with the largest group purchasing program in the life sciences
  • Connect with other executives, entrepreneurs, partners, and customers
  • Impact public policy in Albany and Washington
  • Support the growth of New York's life science industry

    Premier Members




Become a Member 

Apply and start receiving your membership benefits today! 


Help for Entrepreneurs 

Complimentary membership and special benefits for small companies


Become a Sponsor 

Support the biotech, pharma and life science industries in New York State. 


Featured Event


Wednesday, Sept 9

8:30-10:30 AM

Offices of Moses & Singer

Chrysler Building

405 Lexington Ave, NYC


Register Now





  • PROFESSOR & CHAIR Genetics and Genomic Sciences

Eric Schadt, PhD, is Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai. 

    Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology.  He is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology in order to more accurately model the complexity of biological systems. He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer's disease.  

    Prior to joining Mount Sinai in 2011, he was Chief Scientific Officer at Pacific Biosciences.  Previously, Dr. Schadt was Executive Scientific Director of Genetics at Rosetta Inpharmatics, a subsidiary of Merck & Co., and before Rosetta, Dr. Schadt was a Senior Research Scientist at Roche Bioscience.  He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics from University of California, Davis, and his Ph.D. in bio-mathematics from University of California, Los Angeles (requiring Ph.D. candidacy in molecular biology and mathematics).  


NewYorkBIO Members: $65


Future Members: $95


Register Now

About the CSO Leadership Series

Chief Science Officers and Chief Medical Officers have a tough job--organizing and managing R&D; uncovering new disruptive discovery and development models; assessing the impact of pricing, reimbursement, and regulation--all while raising capital, working with investors, and strategizing appropriate exits.

NewYorkBIO's CSO Leadership Series is designed to help bioscience CSO/CMOs to engage with experienced industry leaders and address the unique challenges associated with the job. Attendees will gain guidance on strategic planning, exit planning, and insight into the trends affecting the future of medical research in the emerging life science space

Limited to 25 attendees, the CSO Leadership Series is restricted to life science executives (no service providers beyond the sponsor) and will offer a unique opportunity to hear directly fro--and to network with--New York's life science leadership.


Exclusive CEO Leadership Series Sponsor


    Upcoming Events


CSO Leadership Series w/ Eric Schadt, PhD
Wednesday, September 9, 2015
Association of University Research Parks International Conference 2015
September 29 - October 2, 2015
CEO Breakfast Club with Bryan Spielman, EVP, Medidata
Wednesday, October 14, 2015
Medtech2015: Convergence
October 14-15, 2015
BIO Latin America
October 14-16, 2015
Issues and Challenges for Emerging Companies (Fellows Only)
Tuesday, October 20, 2015
BIO Investor Forum
October 20-21, 2015
Partnering for Cures
November 1-3, 2015
Who Needs a VC 2: New Models for Financing Biomedical Research
Wednesday, November 4, 2015
Supply Chain Summit
Wednesday, November 11, 2015
Biotech and Money New York
Tuesday, November 17, 2015



Welcome to our New Members

Chestnut Hill, MA

Accutar Biotechnology Inc.
Brooklyn, NY

Adjuvance Technologies Inc.
New York, NY

Allovate, LLC
New York, NY

Berkshire Sterile Manufacturing, Inc.
Lee, MA

Cellectis Inc.
New York, New York

Celleritas Bioscience LLC
Brooklyn, NY

Claymore Technologies, Inc
New York, NY

ConSynanceTherapeutics, Inc.
Schenectady, NY

Immix Biopharma

Immune Pharmaceuticals Corp.
New York, NY

Innovimmune Biotherapeutics Holding, LLC
Brooklyn, NY

Johnson & Johnson Innovation Center
Cambridge, MA

Kaneka Americas Holding, Inc.
New York, NY

MagnePath USA, Inc.
New York, NY

Navitas Pharma, Inc.
New York, NY

Optologix, LLC

Population Diagnostics Inc
Melville, NY

QB Sonic, Inc.
Stony Brook, NY

Ithaca, NY

S3B Consulting, LLC
Montclair, NJ

Saptalis Pharmaceuticals. Inc
Hauppauge, NY

Sovereign Laboratories
Glen Rock, NJ

New York, NY

Superlative BioSciences Corporation
Manlius, NY

Sveikatal, Inc.
New York, NY

True Synthesis LLC
New York, NY


United Biomedical Inc.
Hauppauge, NY

VentriNova, Inc.
New York, NY

New York, NY